Company: LCTX
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0000950170-25-070337
Chunk: 0

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On May 13, 2025, Lineage Cell Therapeutics, Inc. issued a press release announcing financial results for the quarter ended March 31, 2025, a copy of which is furnished as Exhibit 99.1.

The information under this Item 2.02 and in Exhibit 99.1 is being furnished and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), and is not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such a filing.